+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report by Test (Molecular, Conventional), Infection (UTI, Pneumonia), Product, Type, and Region with Growth Forecasts, 2025-2030- Product Image
Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report by Test (Molecular, Conventional), Infection (UTI, Pneumonia), Product, Type, and Region with Growth Forecasts, 2025-2030- Product Image
New

Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report by Test (Molecular, Conventional), Infection (UTI, Pneumonia), Product, Type, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 70 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 5914579
Description Jump to:
The Hospital Acquired Infections Diagnostics Market was valued at USD 4.29 billion in 2024, and is projected to reach USD 4.74 billion by 2030, rising at a CAGR of 1.49%. The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR of 1.49% during the period of 2025 to 2030. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2025 to 2030.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Hospital Acquired Infections Diagnostics Market Report Highlights

  • The consumables segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR of 1.55% over the forecast period,
  • The blood tests segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR of 1.55% during the forecast period
  • Europe dominated the market and accounted for the largest revenue share of 34.57% in 2024, owing to the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test
1.1.2. Infection
1.1.3. Product
1.1.4. Type
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test outlook
2.2.2. Infection outlook
2.2.3. Product outlook
2.2.4. Type outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Hospitals Acquired Infections Diagnostics: Test Estimates & Trend Analysis
4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
4.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Conventional
4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Molecular
4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Hospital Acquired Infections Diagnostics: Infection Estimates & Trend Analysis
5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
5.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. UTI
5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Pneumonia
5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Surgical Site Infection
5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Blood Stream Infections
5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Hospital Acquired Infections Diagnostics: Product Estimates & Trend Analysis
6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
6.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Consumables
6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Instruments
6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis
7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
7.2. Type Outlook
7.2.1. Type Outlook market estimates and forecasts, 2018 to 2030 (USD Million)
7.3. Blood Tests
7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Urinalysis
7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key Country Dynamics
8.4.1.2. Competitive Scenario
8.4.1.3. Regulatory Framework
8.4.1.4. Reimbursement Scenario
8.4.1.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.6. Denmark
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.7. Sweden
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.8. Norway
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Reimbursement Scenario
8.4.8.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key Country Dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory Framework
8.5.1.4. Reimbursement Scenario
8.5.1.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Scenario
8.5.4.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Reimbursement Scenario
8.5.5.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement Scenario
8.5.6.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. Reimbursement Scenario
8.6.1.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.6.2. Argentina
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Reimbursement Scenario
8.7.1.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement Scenario
8.7.2.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement Scenario
8.7.3.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Reimbursement Scenario
8.7.4.5. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Company Market Share Analysis, 2024
9.4. Company Profiles
9.4.1. BIOMÉRIEUX
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Abbott
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. F. Hoffmann-La Roche Ltd
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Siemens Healthcare Private Limited
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BD (Becton, Dickinson and Company)
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Hologic, Inc.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Meridian Bioscience, Inc
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. QIAGEN
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Thermo Fisher Scientific Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Bioscience, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018-2030 (USD Million)
Table 4 North America hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 5 North America hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 6 North America hospital acquired infections diagnostics market, by region, 2018-2030 (USD Million)
Table 7 U.S. hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 8 U.S. hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 11 Canada hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 12 Canada hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 13 Canada hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 14 Canada hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 15 Mexico hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 16 Mexico hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 17 Mexico hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 18 Mexico hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 19 Europe hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 20 Europe hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 21 Europe hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 22 Europe hospital acquired infections diagnostics market, by region, 2018-2030 (USD Million)
Table 23 UK hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 24 UK hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 25 UK hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 26 UK hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 27 Germany hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 28 Germany hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 29 Germany hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 30 Germany hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 31 France hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 32 France hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 33 France hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 34 France hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 35 Italy hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 36 Italy hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 37 Italy hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 38 Italy hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 39 Spain hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 40 Spain hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 41 Spain hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 42 Spain hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 43 Denmark hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 44 Denmark hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 45 Denmark hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 46 Denmark hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 47 Sweden hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 48 Sweden hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 49 Sweden hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 50 Sweden hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 51 Norway hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 52 Norway hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 53 Norway hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 54 Norway hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 55 Asia Pacific hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 56 Asia Pacific hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 57 Asia Pacific hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 58 Asia Pacific hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 59 Asia Pacific hospital acquired infections diagnostics market, by region, 2018-2030 (USD Million)
Table 60 Japan hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 61 Japan hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 62 Japan hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 63 Japan hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 64 China hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 65 China hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 66 China hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 67 China hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 68 India hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 69 India hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 70 India hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 71 India hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 72 Australia hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 73 Australia hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 74 Australia hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 75 Australia hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 76 Thailand hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 77 Thailand hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 78 Thailand hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 79 Thailand hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 80 South Korea hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 81 South Korea hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 82 South Korea hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 83 South Korea hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 84 Latin America hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 85 Latin America hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 86 Latin America hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 87 Latin America hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 88 Latin America hospital acquired infections diagnostics market, by region, 2018-2030 (USD Million)
Table 89 Brazil hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 90 Brazil hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 91 Brazil hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 92 Brazil hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 93 Argentina hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 94 Argentina hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 95 Argentina hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 96 Argentina hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 97 Middle East and Africa hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 98 Middle East and Africa hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 99 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 100 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 101 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018-2030 (USD Million)
Table 102 South Africa hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 103 South Africa hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 104 South Africa hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 105 South Africa hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 106 Saudi Arabia hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 107 Saudi Arabia hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 108 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 109 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 110 UAE hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 111 UAE hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 112 UAE hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 113 UAE hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
Table 114 Kuwait hospital acquired infections diagnostics market, by test, 2018-2030 (USD Million)
Table 115 Kuwait hospital acquired infections diagnostics market, by infection, 2018-2030 (USD Million)
Table 116 Kuwait hospital acquired infections diagnostics market, by product, 2018-2030 (USD Million)
Table 117 Kuwait hospital acquired infections diagnostics market, by type, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 QFD modeling for market share assessment
Figure 6 Market formulation & validation
Figure 7 Microneedle Instruments systems: market outlook
Figure 8 Hospital Acquired Infections Diagnostics competitive insights
Figure 9 Parent market outlook
Figure 10 Related/ancillary market outlook
Figure 11 Penetration and growth prospect mapping
Figure 12 Hospital acquired infections diagnostics market driver impact
Figure 13 Hospital acquired infections diagnostics market restraint impact
Figure 14 Hospital acquired infections diagnostics market strategic initiatives analysis
Figure 15 Hospital acquired infections diagnostics market: Test type movement analysis
Figure 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
Figure 17 Molecular market estimates and forecasts, 2018-2030 (USD Million)
Figure 18 Conventional market estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Hospital acquired infections diagnostics market: Infection type movement analysis
Figure 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
Figure 21 UTI market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Pneumonia market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Surgical site infection market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Blood stream infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Hospital acquired infections diagnostics market: Product movement analysis
Figure 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
Figure 28 Consumables market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 2030 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
Figure 31 Blood tests market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Urinalysis market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Global hospital acquired infections diagnostics market: Regional movement analysis
Figure 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
Figure 36 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this Hospital Acquired Infections Diagnostics market report include:
  • bioMérieux S.A
  • Abbott
  • Hoffmann-La Roche Ltd
  • Siemens Healthcare Private Limited
  • BD (Becton, Dickinson, and Company)
  • Bioscience, Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Meridian Bioscience, Inc.
  • Hologic, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages70
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.74 Billion
Compound Annual Growth Rate1.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hospital Acquired Infection Control Market Size, Share and Trends Analysis Report by Type (Equipment, Services, Consumables), End-use (Hospitals & ICUs, Ambulatory Surgical and Diagnostic Centers), and Region 2024-2030 - Product Image

Hospital Acquired Infection Control Market Size, Share and Trends Analysis Report by Type (Equipment, Services, Consumables), End-use (Hospitals & ICUs, Ambulatory Surgical and Diagnostic Centers), and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2025-2030 - Product Image

Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Healthcare-associated Infectious Disease Diagnostics Market by Product & Service, Disease Type, End-user - Global Forecast 2025-2030 - Product Image

Healthcare-associated Infectious Disease Diagnostics Market by Product & Service, Disease Type, End-user - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Hospital Acquired Infections Testing Kits Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Hospital Acquired Infections Testing Kits Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 153 Pages
  • Global
From
Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.